Literature DB >> 33170491

Rosacea Treatment: Review and Update.

Hanlin Zhang1, Keyun Tang1, Yuchen Wang1, Rouyu Fang1, Qiuning Sun2.   

Abstract

Rosacea is a chronic and inflammatory skin disease characterized by flushing, nontransient erythema, papules/pustules, telangiectasia, and phymatous changes. Secondary manifestations, such as itching, burning, or stinging, are often observed in patients with rosacea. In 2017, a phenotype-based approach for diagnosis and classification was recommended. With the update of the diagnosis and classification of rosacea, treatment options for patients with rosacea have attracted the attention of dermatologists. Here, we summarize the latest advances in rosacea treatment, including skin care and cosmetic treatments, topical therapies, oral therapies, laser- and light-based therapies, injection therapies, treatments for specific types of rosacea, treatments for systemic comorbidities, and combination therapies. The impact of the phenotype-based approach on rosacea treatment and future directions are also discussed.

Entities:  

Keywords:  Oral therapies; Rosacea; Systemic comorbidities; Topical therapies; Treatment

Year:  2020        PMID: 33170491     DOI: 10.1007/s13555-020-00461-0

Source DB:  PubMed          Journal:  Dermatol Ther (Heidelb)


  11 in total

Review 1.  Skin Conditions and Movement Disorders: Hiding in Plain Sight.

Authors:  Kristina Kulcsarova; Janette Baloghova; Jan Necpal; Matej Skorvanek
Journal:  Mov Disord Clin Pract       Date:  2022-03-24

2.  Serum Level of Brain-Derived Neurotrophic Factor (BDNF) Associated with Depression in Patients with Rosacea: A Candidate Predictive Biomarker.

Authors:  Tegexibaiyin Wang; Fen Liu; Xiujuan Jia; Jing Tan; Baopeng Qi; Jingxue Guo; Qiri Mu; Hong Zhang
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-06-02

3.  Use of Botulinum Toxin in Treating Rosacea: A Systematic Review.

Authors:  Hanlin Zhang; Keyun Tang; Yuanzhuo Wang; Rouyu Fang; Qiuning Sun
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-04-30

4.  Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea.

Authors:  Huaxiong Zhang; Yiya Zhang; Yangfan Li; Yaling Wang; Sha Yan; San Xu; Zhili Deng; Xinling Yang; Hongfu Xie; Ji Li
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

5.  Multi-Transcriptomic Analysis and Experimental Validation Implicate a Central Role of STAT3 in Skin Barrier Dysfunction Induced Aggravation of Rosacea.

Authors:  Yaling Wang; Ben Wang; Yingxue Huang; Yangfan Li; Sha Yan; Hongfu Xie; Yiya Zhang; Ji Li
Journal:  J Inflamm Res       Date:  2022-03-31

6.  Increased Frequency of Circulating Classical Monocytes in Patients with Rosacea.

Authors:  Cuie Gao; Lan Ge; Dewei Chen; Mengjie Zhang; Li Zhao; Wenying Liu; Shuguang Chen; Juan Wang; Cunjian Zhou; Xingwang Zhao; Shifei Li; Zhiqiang Song; Jian Li
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-09

7.  Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay.

Authors:  Yaqun Huang; Sha Yan; Hongfu Xie; Ben Wang; Zhixiang Zhao; Yingxue Huang; Ji Li
Journal:  Patient Prefer Adherence       Date:  2022-03-06       Impact factor: 2.711

8.  The effects of photobiomodulation therapy on inflammatory mediators, immune infiltration, and angiogenesis in a mouse model of rosacea.

Authors:  Shuwei Wu; Yaoxi Su; Lian Wang; Bensen Sun; Xian Jiang
Journal:  Ann Transl Med       Date:  2022-08

9.  Willingness-to-Pay and Benefit-Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey.

Authors:  Xizhao Yang; Yuyan Ouyang; Yuxuan Deng; Yi Xiao; Yan Tang; Dan Jian; Ji Li; Hongfu Xie; Yingxue Huang
Journal:  Patient Prefer Adherence       Date:  2021-06-03       Impact factor: 2.711

10.  Sodium Bituminosulfonate Used to Treat Rosacea Modulates Generation of Inflammatory Mediators by Primary Human Neutrophils.

Authors:  Susanne Schiffmann; Sandra Gunne; Marina Henke; Thomas Ulshöfer; Dieter Steinhilber; Annette Sethmann; Michael J Parnham
Journal:  J Inflamm Res       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.